Implantable infusion device

Patent metadata

Field	Value
Publication number	US-9259530-B2
Application number	US-62569409-A
Country	US
Kind code	B2
Filing date	Nov 25, 2009
Priority date	Nov 25, 2009
Publication date	Feb 16, 2016
Grant date	Feb 16, 2016

Abstract

An implantable infusion device includes a positive pressure reservoir, a pump, a flow restrictor, and an outlet. The device includes a first fluid flow path from the reservoir to the outlet, where the pump is downstream of the reservoir, and the outlet is downstream of the pump. The device further includes a second fluid flow path from the reservoir to the outlet, where the flow restrictor is downstream of the reservoir, and the outlet is downstream of the restrictor. The device may also include one or more controllable, MRI-safe valves to select whether fluid is delivered via the first or second flow path.

First claim

What is claimed is:

1. An implantable infusion device comprising:
a positive pressure reservoir;
a pump;
a flow restrictor;
an outlet,
a first fluid flow path from the reservoir to the outlet, wherein the first fluid flow path includes the pump but not the flow restrictor, and wherein the pump is downstream of the reservoir, and the outlet is downstream of the pump;
a second fluid flow path from the reservoir to the outlet, wherein the second fluid flow path includes the flow restrictor but not the pump, and wherein the flow restrictor is downstream of the reservoir, and the outlet is downstream of the flow restrictor,
a first controllable valve, wherein the second flow path includes the first controllable valve upstream of the flow restrictor and downstream of the reservoir, wherein the first controllable valve is stable when exposed to a magnetic field;
a second controllable valve, wherein the first flow path includes the second controllable valve downstream of the pump and upstream of the outlet; and
third fluid flow path from the pump to the first controllable valve,
wherein the first controllable valve is configured to prevent flow from the reservoir to the outlet via the second flow path unless the second controllable valve is closed and the pump is activated,
wherein the first controllable valve comprises a first chamber in communication with the pump via the third flow path, a second chamber in communication with the reservoir via the second flow path, and a diaphragm sealingly dividing the first and second chambers.

2. The device of claim 1 , wherein the first controllable valve further comprises a sealing member, a third chamber in communication with the second chamber and the restrictor, wherein the sealing member is operably coupled to the diaphragm and is configured to permit fluid to flow from the second chamber to the third chamber or to fluidly seal the third chamber relative to the second chamber.

3. An implantable infusion device comprising:
a positive pressure reservoir;
a pump;
a flow restrictor;
an outlet,
a first fluid flow path from the reservoir to the outlet, wherein the first fluid flow path includes the pump but not the flow restrictor, and wherein the pump is downstream of the reservoir, and the outlet is downstream of the pump;
a second fluid flow path from the reservoir to the outlet, wherein the second fluid flow path includes the flow restrictor but not the pump, and wherein the flow restrictor is downstream of the reservoir, and the outlet is downstream of the flow restrictor,
a first controllable valve, wherein the second flow path includes the first controllable valve upstream of the flow restrictor and downstream of the reservoir, wherein the first controllable valve is stable when exposed to a magnetic field;
a second controllable valve, wherein the first flow path includes the second controllable valve downstream of the pump and upstream of the outlet;
third fluid flow path from the pump to the first controllable valve,
wherein the first controllable valve is configured to prevent flow from the reservoir to the outlet via the second flow path unless the second controllable valve is closed and the pump is activated; and

a fourth leakage flow path configured to provide a leakage flow from the first controllable valve to the flow restrictor.

4. The device of claim 3 , wherein the first controllable valve comprises a first chamber in communication with the pump via the third flow path, a second chamber in communication with the reservoir via the second flow path, and a diaphragm sealingly dividing the first and second chambers, wherein the first chamber comprises a bleed hole in communication with the fourth leakage pathway.

5. An implantable infusion device comprising:
a positive pressure reservoir;
a pump;
a flow restrictor;
an outlet,
a first fluid flow path from the reservoir to the outlet, wherein the first fluid flow path includes the pump but not the flow restrictor, and wherein the pump is downstream of the reservoir, and the outlet is downstream of the pump;
a second fluid flow path from the reservoir to the outlet, wherein the second fluid flow path includes the flow restrictor but not the pump, and wherein the flow restrictor is downstream of the reservoir, and the outlet is downstream of the flow restrictor,
a first controllable valve, wherein the second flow path includes the first controllable valve upstream of the flow restrictor and downstream of the reservoir, wherein the first controllable valve is stable when exposed to a magnetic field;
a second controllable valve, wherein the first flow path includes the second controllable valve downstream of the pump and upstream of the outlet;
third fluid flow path from the pump to the first controllable valve,
wherein the first controllable valve is configured to prevent flow from the reservoir to the outlet via the second flow path unless the second controllable valve is closed and the pump is activated,
wherein the second controllable valve has an open state and a closed state and wherein the device further comprises control electronics operably coupled to the second controllable valve and the pump, wherein the control electronics are configured to provide instructions to close the second controllable valve and to cause the pump to deliver fluid to the first controllable valve to open the first controllable valve and permit fluid to flow from the reservoir to the outlet via the second flow path; and

a third controllable valve in the second fluid pathway, wherein the third controllable valve is downstream of the flow restrictor, and the outlet is downstream of the third controllable valve.

6. The device of claim 5 , wherein the control electronics are configured to cause the third controllable valve to cycle between an open state and a closed state to control the rate at which fluid is delivered to the outlet via the second flow path.

Assignees

• Christenson Steven R
• Medtronic Inc

Inventors

• Christenson Steven R

Classifications

• A61M5/141

  with capillaries for restricting fluid flow · CPC title

• A61M5/14276 Primary

  specially adapted for implantation · CPC title

• A61M2039/0244

  having means for detecting an inserted needle · CPC title

• A61M2039/242

  designed to open when a predetermined pressure or flow rate has been reached, e.g. check valve actuated by fluid · CPC title

• A61M5/16813

  by controlling the degree of opening of the flow line · CPC title